Sign In
Buy TCON
$0.0322
+0 (+0%)
At Close: Oct 15, 2025
TRACON Pharmaceuticals Announces it Will Wind Down Operations
04:44pm, Tuesday, 30'th Jul 2024
SAN DIEGO, July 30, 2024 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (OTCQB: TCON) today announced that the Company has terminated its employees and will wind down its operations. This decision was mad
Publication Highlights Activity of the Combination of TRC102 and Temodar (Temozolomide) in Patients who Progressed Following Initial Treatment with Surgical Resection, Temodar and External Beam Radiot
TRACON Pharmaceuticals, Inc. (TCON) Q1 2024 Earnings Call Transcript
08:48pm, Tuesday, 14'th May 2024
TRACON Pharmaceuticals, Inc. (NASDAQ:TCON ) Q1 2024 Earnings Conference Call May 14, 2024 4:30 PM ET Company Participants Charles Theuer - President & CEO Scott Brown - CFO Conference Call Participant
TRACON Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update
04:01pm, Tuesday, 14'th May 2024
SAN DIEGO, May 14, 2024 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company utilizing a cost-efficient, CRO-independent product development plat
TRACON to Report First Quarter 2024 Financial Results and Provide Corporate Update on May 14, 2024
04:01pm, Tuesday, 07'th May 2024
SAN DIEGO, May 07, 2024 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company utilizing a cost-efficient, CRO-independent product development plat
Wall Street Favorites: 3 Penny Stocks With Strong Buy Ratings for April 2024
06:30am, Wednesday, 10'th Apr 2024
Now could be a great time for investors to consider stacking up on penny stocks. These companies often have significant growth potential.
TRACON Pharmaceuticals Announces Reverse Stock Split
09:10am, Monday, 08'th Apr 2024
SAN DIEGO, April 08, 2024 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stage biopharmaceutical company utilizing a cost-efficient, CRO-independent Product Development Platform
TRACON Pharmaceuticals, Inc. (TCON) Q4 2023 Earnings Call Transcript
10:37pm, Tuesday, 05'th Mar 2024
TRACON Pharmaceuticals, Inc. (TCON) Q4 2023 Earnings Call Transcript
TRACON Pharmaceuticals Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update
04:02pm, Tuesday, 05'th Mar 2024
SAN DIEGO, March 05, 2024 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company utilizing a cost-efficient, CRO-independent product development pl
TRACON to Report Fourth Quarter and Year-End 2023 Financial Results and Provide Corporate Update on March 5, 2024
04:02pm, Wednesday, 28'th Feb 2024
SAN DIEGO, Feb. 28, 2024 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company utilizing a cost-efficient, CRO-independent product development pla
TRACON Pharmaceuticals Provides Positive Update on Ongoing ENVASARC Pivotal Phase 2 Trial
08:00am, Wednesday, 20'th Dec 2023
Objective Response Rate by investigator review increased to 15% since interim analysis in September Full ENVASARC enrollment expected in 1Q 2024 and final data anticipated during 3Q 2024 SAN DIEGO, De
Why Is Tracon Pharmaceuticals (TCON) Stock Up 19% Today?
07:55am, Tuesday, 21'st Nov 2023
Tracon Pharmaceuticals (NASDAQ: TCON ) stock is rocketing higher on Tuesday as investors react to a licensing agreement for its product development platform ( PDP ). According to a press release from
TRACON Pharmaceuticals Announces License of Product Development Platform for $3.0 Million Upfront Payment
08:00am, Monday, 20'th Nov 2023
SAN DIEGO, Nov. 20, 2023 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company utilizing a cost-efficient, CRO-independent product development pla
Why Is Tracon Pharmaceuticals (TCON) Stock Down 22% Today?
09:29am, Monday, 13'th Nov 2023
Tracon Pharmaceuticals (NASDAQ: TCON ) stock is falling on Monday as the company's shares retreat from a massive rally on Friday. That rally saw shares of TCON stock climb 43.9% higher during normal
Why Is Tracon Pharmaceuticals (TCON) Stock Up 130% Today?
07:45am, Friday, 10'th Nov 2023
Tracon Pharmaceuticals (NASDAQ: TCON ) stock is rocketing higher on Friday after the biopharmaceutical company announced results for the third quarter of 2023. Tracon Pharmaceuticals starts its report
